Key facts
- Dally’s last known valuation is $2.5M (Dec 2025).
- It has raised $200K; the latest was Angel (individual) ($200K) in Dec 2025.
- Notable investors include 2i3T.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Dally
- ·The full record, as it builds
Funding rounds
No funding rounds for Dally are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Dally
Developer of a diabetes management application designed to support personal well-being. The company's platform provides daily recommendations, a unified health diary, learning resources, and data-driven insights, enabling individuals to understand their habits, improve self-care, and manage diabetes with greater confidence.
- Sector
- Healthcare
- HQ
- Turin, Italy
- Founded
- 2022
- Employees
- 6
- Website
- dally.it/
- Ownership
- Privately Held (backing)
Dally doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Dally shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Dally in its N-PORT filings yet. We sweep new filings monthly.